RxDoctor Payments Data

John Bracey, MD

Hand Surgery · Little Rock, ARNPI 1922325737

Payments from drug & device makers

What this record shows

This record is dominated by education: $2,322 of the $2,993 with a category attached, or 77.6%. Midsouth Orthopedics Inc. accounts for 77.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $2,378 and has fallen 93.2% since, to $162 in 2025.

$2,993in general payments, 2019–2025

Across 11 payments — averaging $272.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Midsouth Orthopedics Inc.$2K
  • Axogen$321
  • Integra Lifesciences Corporation$186
  • Acumed LLC$101
  • Checkpoint Surgical, Inc$51
  • Exsomed Corporation$13

What the payments were for

  • Food & beverage$67122%
  • Education$2,32278%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Midsouth Orthopedics Inc.1$2,322
Axogen4$321
Integra Lifesciences Corporation2$186
Acumed LLC2$101
Checkpoint Surgical, Inc1$51
Exsomed Corporation1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few hand surgery providers in Arkansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$101,447
Medicare patients
186
Services billed
768

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin75$1,255
Clindamycin Hcl19$224
Meloxicam22$58

Paid to pharmacies, not to this prescriber.

Other hand surgery in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →